| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2003-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003515543-A |
| titleOfInvention |
14,15-beta-methylene substituted androgens |
| abstract |
(57) [Summary]nThe disclosed invention relates to the unexpected discovery of novel steroids characterized by a 14β, 15β-cyclopropane ring and a 17α hydroxymethyl group. These steroids according to the present invention have been found to have androgenic activity in common. They can be used for the preparation of male contraceptives as well as for the preparation of medicaments for the treatment of androgen deficiency. |
| priorityDate |
1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |